[The research progress of laryngotracheal stenosis in children]

    Insights

    Pediatric laryngotracheal stenosis, a narrowing of the airway due to scar tissue, is increasing in children due to intensive care practices like tracheal intubation. This condition requires complex treatments and impacts quality of life.

    Area of Science:

    • Pediatric Otolaryngology
    • Respiratory Medicine
    • Pediatric Surgery

    Context:

    • Laryngotracheal stenosis in children is a growing concern, often resulting from congenital factors or acquired causes like prolonged tracheal intubation in intensive care settings.
    • The increasing use of mechanical ventilation in neonates and critically ill children has led to a rise in the incidence of pediatric airway compromise.
    • This condition significantly impacts a child's breathing and necessitates multiple, often challenging, surgical interventions.

    Purpose:

    • To provide a comprehensive overview of pediatric laryngotracheal stenosis.
    • To detail the classification, etiological factors, and clinical presentations of this condition.
    • To review current diagnostic methods and treatment advancements for pediatric airway stenosis.

    Summary:

    • Pediatric laryngotracheal stenosis involves scar tissue formation that narrows the airway, impairing breathing in children.
    • Etiologies include congenital issues and acquired factors, notably tracheal intubation in premature and critically ill infants.
    • Diagnosis relies on clinical evaluation and imaging, while treatment involves complex surgical procedures with varying success rates.

    Impact:

    • Highlights the increasing prevalence and challenges associated with pediatric airway stenosis.
    • Underscores the need for effective diagnostic and therapeutic strategies to improve outcomes.
    • Emphasizes the significant impact of the condition on a child's long-term health and family quality of life.

    Related Concept Videos

    Mitral Stenosis I: Introduction01:22

    Mitral Stenosis I: Introduction

    Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
    633
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    7.4K
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    301
    Mitral Stenosis IV: Nursing Management01:27

    Mitral Stenosis IV: Nursing Management

    A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
    286
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    4.8K
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    295